Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Human Microbiome Market, by Product
1.4.2 North America Human Microbiome Market, by Disease Type
1.4.3 North America Human Microbiome Market, by Technology
1.4.4 North America Human Microbiome Market, by Application
1.4.5 North America Human Microbiome Market, by Type
1.4.6 North America Human Microbiome Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Human Microbiome Market by Product
3.1 North America Drugs Market by Country
3.2 North America Diagnostic Tests Market by Country
3.3 North America Probiotics Market by Country
3.4 North America Prebiotics Market by Country
3.5 North America Others Market by Country
Chapter 4. North America Human Microbiome Market by Disease Type
4.1 North America Infectious Diseases Market by Country
4.2 North America Endocrine & Metabolic Disorders Market by Country
4.3 North America Gastrointestinal Diseases Market by Country
4.4 North America Cancer Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Human Microbiome Market by Technology
5.1 North America Genomics Market by Country
5.2 North America Proteomics Market by Country
5.3 North America Metabolomics Market by Country
Chapter 6. North America Human Microbiome Market by Application
6.1 North America Therapeutics Market by Country
6.2 North America Diagnostics Market by Country
Chapter 7. North America Human Microbiome Market by Type
7.1 North America Microbiome Consortia Transplantation (FMT) Market by Country
7.2 North America Peptide Market by Country
7.3 North America Live Biotherapeutic Product Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Human Microbiome Market by Country
8.1 US Human Microbiome Market
8.1.1 US Human Microbiome Market by Product
8.1.2 US Human Microbiome Market by Disease Type
8.1.3 US Human Microbiome Market by Technology
8.1.4 US Human Microbiome Market by Application
8.1.5 US Human Microbiome Market by Type
8.2 Canada Human Microbiome Market
8.2.1 Canada Human Microbiome Market by Product
8.2.2 Canada Human Microbiome Market by Disease Type
8.2.3 Canada Human Microbiome Market by Technology
8.2.4 Canada Human Microbiome Market by Application
8.2.5 Canada Human Microbiome Market by Type
8.3 Mexico Human Microbiome Market
8.3.1 Mexico Human Microbiome Market by Product
8.3.2 Mexico Human Microbiome Market by Disease Type
8.3.3 Mexico Human Microbiome Market by Technology
8.3.4 Mexico Human Microbiome Market by Application
8.3.5 Mexico Human Microbiome Market by Type
8.4 Rest of North America Human Microbiome Market
8.4.1 Rest of North America Human Microbiome Market by Product
8.4.2 Rest of North America Human Microbiome Market by Disease Type
8.4.3 Rest of North America Human Microbiome Market by Technology
8.4.4 Rest of North America Human Microbiome Market by Application
8.4.5 Rest of North America Human Microbiome Market by Type
Chapter 9. Company Profiles
9.1 Ferring Holdings SA
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research and Development Expense
9.1.5 Recent Strategies and Developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
9.2.1 Company Overview
9.2.2 Recent Strategies and Developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expense
9.3.4 Recent Strategies and Developments:
9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent Strategies and Developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
9.5.1 Company Overview
9.6 Synlogic, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
Unique Offerings 
